Chou Associates Management Teva Pharma Industries Ltd ADR transactions over time
TEVA-OLD
Teva Pharma Industries Ltd ADR historical holders
total: 10
Transactions details
- Total transactions:
- 4
- New positions:
- 1
- Sold out:
- 1
- Added:
- 1
- Reduced:
- 1
- Held since:
- 2017 Q1
- Held for:
- 11 quarters
- Latest activity:
- 2019 Q4
Francis Chou has been an institutional investor in Teva Pharma Industries Ltd ADR (TEVA-OLD) since 2017 Q1. According to 2026 Q2 report, Francis Chou doesn't hold any shares. The fund/company first acquired TEVA-OLD in 2017 Q1, initially purchasing 215,000 shares. Since the initial investment, Chou Associates Management has made 3 more transactions in this position.
When did Francis Chou exit their TEVA-OLD position?
Francis Chou no longer holds Teva Pharma Industries Ltd ADR (TEVA-OLD). They sold off their entire position in 2019 Q4, closing out an investment that began in 2017 Q1.
When did Francis Chou first invest in TEVA-OLD?
Francis Chou first invested in Teva Pharma Industries Ltd ADR (TEVA-OLD) in 2017 Q1 at the reported quarter-end price of $32.09 per share, acquiring 215,000 shares in their initial purchase.
What is Francis Chou's average cost basis for TEVA-OLD?
Based on historical transaction data, Francis Chou's estimated cost basis for Teva Pharma Industries Ltd ADR (TEVA-OLD) is approximately $32.81 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $32.81
- Weighted AVG sell price:
- $18.58
TEVA-OLD transactions history by Chou Associates Management
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2019 Q4
|
0.00%
|
$6.87
|
-100% (-15,000)
|
|||
|
2017 Q4
|
0.12%
|
$18.93
|
-97.03% (-490,000)
|
|||
|
2017 Q2
|
5.20%
|
$33.34
|
+134.88% (+290,000)
|
|||
|
2017 Q1
|
2.29%
|
$32.09
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.